Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE study.
Emek KocatürkMona Al-AhmadKaroline KrauseGimenez-Arnau Ana MariaSimon Francis ThomsenNiall ConlonAlexander MarslandEkin SavkRoberta F CriadoInna DanilychevaDaria FominaKiran GodseMaryam KhoshkhuiAslı GelincikEce Nur DegirmentepeSemra DemirLuis Felipe EnsinaAlicja Kasperska-ZajacMichael RudenkoSolange Oliveira Rodrigues ValleIris MedinaAndrea BauerZuotao ZhaoPetra StaubachLaurence BouilletOzlem Su KucukArzu BaygülMarcus MaurerPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Most CU patients used treatment during pregnancy especially second-generation antihistamines which seem to be safe during pregnancy regardless of the trimester. The rates of preterm births and medical problems of new-borns in CU patients were similar to population norms and not linked to treatment used during pregnancy. Emergency referrals for CU increased the risk of preterm birth and emphasize the importance of sufficient treatment to keep urticaria under control during pregnancy.